Kovitz Investment Group Partners, LLC Bristol Myers Squibb CO Transaction History
Kovitz Investment Group Partners, LLC
- $28.6 Billion
- Q4 2024
A detailed history of Kovitz Investment Group Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 91,920 shares of BMY stock, worth $5.05 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
91,920
Previous 91,920
-0.0%
Holding current value
$5.05 Million
Previous $5.2 Million
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
25 transactions
Others Institutions Holding BMY
# of Institutions
2,749Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.72 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.28 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.23 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.32 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $117B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...